Florida Surgeon General Dr. Joseph Ladapo warned that the Pfizer and Moderna COVID-19 mRNA vaccines present cancer risks.
In a press release detailing the vaccine’s safety concerns, Ladapo cited a study revealing the “presence of billions to hundreds of billions of DNA molecules per dose in the modRNA COVID-19 products tested.”
He then referred to guidance from the FDA describing how “DNA integration could theoretically impact a human’s oncogenes – the genes which can transform a healthy cell into a cancerous cell.”
Ladapo discussed a December 6 letter to Food and Drug Administration (FDA) Commissioner Dr. Robert M. Califf and Center for Disease Control and Prevention (CDC) Director Dr. Mandy Cohen, noting the “presence of nucleic acid contaminants in the approved Pfizer and Moderna COVID-19 mRNA vaccines.”
“This raises concerns regarding the presence of nucleic acid contaminants in the approved Pfizer and Moderna COVID-19 mRNA vaccines, particularly in the presence of lipid nanoparticle complexes, and Simian Virus 40 (SV40) promoter/enhancer DNA. Lipid nanoparticles are an efficient vehicle for delivery of the mRNA in the COVID-19 vaccines into human cells, and may therefore be an equally efficient vehicle for delivering contaminant DNA into human cells. The presence of SV40 promoter/enhancer DNA may also pose a unique and heightened risk of DNA integration into host cells,” he explained in the letter.
On December 14, the FDA responded to Ladapo’s letter, saying, “No SV40 proteins are encoded for or are present in the vaccines. On first principle, it is quite implausible that the residual small DNA fragments located in the cytosol could find their way into the nucleus through the nuclear membrane present in intact cells and then be incorporated into chromosomal DNA.”
Ladapo has since issued the following statement: “The FDA’s response does not provide data or evidence that the DNA integration assessments they recommended themselves have been performed. Instead, they pointed to genotoxicity studies – which are inadequate assessments for DNA integration risk. In addition, they obfuscated the difference between the SV40 promoter/enhancer and SV40 proteins, two elements that are distinct.”
The surgeon general explained that DNA integration “poses a unique and elevated risk to human health and to the integrity of the human genome.”
“It is my hope that, in regard to COVID-19, the FDA will one day seriously consider its regulatory responsibility to protect human health, including the integrity of the human genome,” he added.
